title: Does suppression of VEGF alone lead to clinical recovery in POEMS syndrome?
authors: Okatsu Neurology and Rehabilitation Hospital, 3-95 Masagohonnmachi, Kagoshima, 890067.
authors: Kimiyoshi
authors: K
authors: Arimura
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000068258:Bevacizumab; D005260:Female; D006801:Humans; D008297:Male; D016878:POEMS Syndrome / Q000188:drug therapy*; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors*
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab
keywords: Neuropathy